noom and glp-1 to offer drug through new weight loss program Interesting claim by Noom Med…

These patches are made for people who want a simpler way to stay on track

The gastrointestinal side effect profile is consistent with other GLP-1 based therapies

This can include paying close attention to factors like nutrition, activity, sleep, and stress

Several human studies are underway to investigate if GLP-1 RAs directly attenuate plaque formation or at least modulate the composition of plaques to a more passive or stable phenotype (Table 3)

Specific Outcomes Even within weight loss, manufacturers have an opportunity to highlight more targeted outcomes, including preservation of lean muscle mass (emphasizing fat loss over muscle loss is critical, particularly for vulnerable populations like the elderly)

1 Charles Barkley has signed on as Ros celebrity ambassador for GLP-1s